{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T22:10:15Z","timestamp":1684534215080},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1157\/13123038","type":"journal-article","created":{"date-parts":[[2008,9,7]],"date-time":"2008-09-07T19:05:19Z","timestamp":1220814319000},"page":"30-34","source":"Crossref","is-referenced-by-count":4,"title":["Nuevas estrategias terap\u00e9uticas para las lesiones anogenitales relacionadas con el virus del papiloma humano en pacientes con infecci\u00f3n por el VIH: tratamiento antirretroviral de gran actividad y vacunas anti-VPH"],"prefix":"10.1016","volume":"131","author":[{"given":"Pere","family":"Fust\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Santamar\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13123038_bb0005","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1157\/13123038_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","article-title":"Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease","volume":"135","author":"Murphy","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1157\/13123038_bb0015","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0959-8049(01)00106-X","article-title":"Impact of HAART on the clinical management of AIDS-related cancers","volume":"37","author":"Tirelli","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1157\/13123038_bb0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.cco.0000239885.13537.36","article-title":"Human papillomavirus-related tumors in HIV","volume":"18","author":"Palefsky","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"10.1157\/13123038_bb0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1468-1293.2006.00395.x","article-title":"The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta","volume":"7","author":"Gingues","year":"2006","journal-title":"HIV Med"},{"key":"10.1157\/13123038_bb0030","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980-2002","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"key":"10.1157\/13123038_bb0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.qco.0000200295.30285.13","article-title":"AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy","volume":"19","author":"Bower","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"10.1157\/13123038_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1532\/IJH97.06088","article-title":"Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy","volume":"84","author":"Bernstein","year":"2006","journal-title":"Int J Hematol"},{"key":"10.1157\/13123038_bb0045","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy","volume":"97","author":"Clifford","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1157\/13123038_bb0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/135965350400900117","article-title":"The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases","volume":"9","author":"Heard","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1157\/13123038_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/154407370601900120","article-title":"Biology of HPV in HIV infection","volume":"19","author":"Palefsky","year":"2006","journal-title":"Adv Dent Res"},{"key":"10.1157\/13123038_bb0060","first-page":"591","article-title":"Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study","volume":"84","author":"Wright","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1157\/13123038_bb0065","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jnci\/91.3.226","article-title":"Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women","volume":"91","author":"Palefsky","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1157\/13123038_bb0070","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/jnci\/95.14.1062","article-title":"Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women","volume":"95","author":"Strickler","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1157\/13123038_bb0075","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/0029-7844(95)00025-M","article-title":"Human papillomavirus infection in human immunodeficiency virus-seropositive women","volume":"85","author":"Sun","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1157\/13123038_bb0080","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/jnci\/92.18.1500","article-title":"Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome","volume":"92","author":"Frisch","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1157\/13123038_bb0085","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1258\/095646206778145703","article-title":"The recurrence of cervical intraepithelial neoplasia in HIV-positive women: a review of the literature","volume":"17","author":"Tebeu","year":"2006","journal-title":"Int J STD AIDS"},{"key":"10.1157\/13123038_bb0090","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1097\/00002030-199812000-00007","article-title":"Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy","volume":"12","author":"Heard","year":"1998","journal-title":"AIDS"},{"key":"10.1157\/13123038_bb0095","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1086\/322856","article-title":"Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy","volume":"184","author":"Lillo","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1157\/13123038_bb0100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0140-6736(02)07368-3","article-title":"HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study","volume":"359","author":"Conley","year":"2002","journal-title":"Lancet"},{"key":"10.1157\/13123038_bb0105","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/381681","article-title":"Antiretroviral therapy and the clinical evolution of human papillomavirus- associated genital lesions in HIV-positive women","volume":"38","author":"Del Mistro","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13123038_bb0110","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/00042560-200112150-00003","article-title":"Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection","volume":"28","author":"Palefsky","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1157\/13123038_bb0115","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/00002030-200111090-00011","article-title":"The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women","volume":"15","author":"Minkoff","year":"2001","journal-title":"AIDS"},{"key":"10.1157\/13123038_bb0120","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/00002030-200209060-00013","article-title":"Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIVseropositive women","volume":"16","author":"Heard","year":"2002","journal-title":"AIDS"},{"key":"10.1157\/13123038_bb0125","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/00002030-200204120-00014","article-title":"Highly active antiretroviral therapy and cervical intraepithelial neoplasia","volume":"16","author":"Moore","year":"2002","journal-title":"AIDS"},{"key":"10.1157\/13123038_bb0130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1086\/375783","article-title":"Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women","volume":"188","author":"Schuman","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1157\/13123038_bb0135","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00002030-199902250-00019","article-title":"Role of highly active antiretroviral therapy in human papillomavirus-induced genital dysplasia in HIV-1-infected patients","volume":"13","author":"Orlando","year":"1999","journal-title":"AIDS"},{"key":"10.1157\/13123038_bb0140","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1067\/mob.2001.111103","article-title":"Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus","volume":"184","author":"Robinson","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1157\/13123038_bb0145","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/01.qai.0000167157.83098.60","article-title":"High rate of recurrence of cervical intraepithelial neoplasia after surgery in HIV-positive women","volume":"39","author":"Heard","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1157\/13123038_bb0150","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygyno.2004.10.003","article-title":"Management and outcome of cervical intraepithelial neoplasia lesions: a study of matched cases according to HIV status","volume":"96","author":"Gilles","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1157\/13123038_bb0155","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/jnci\/djh192","article-title":"Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women","volume":"96","author":"Ahdieh-Grant","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1157\/13123038_bb0160","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.287.16.2120","article-title":"2001 Consensus Guidelines for the management of women with cervical cytological abnormalities","volume":"287","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1157\/13123038_bb0165","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1067\/mob.2003.633","article-title":"2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia","volume":"189","author":"Wright","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1157\/13123038_bb0170","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/154099904322966128","article-title":"HPV testing for triage of HIV-infected women with papanicolaou smears read as atypical squamous cells of uncertain significance","volume":"13","author":"Massad","year":"2004","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1157\/13123038_bb0175","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00126334-200104010-00016","article-title":"Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy","volume":"26","author":"Dorrucci","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1157\/13123038_bb0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00002030-200401020-00013","article-title":"Low incidence of invasive cervical cancer among HIV-infected US women in a prevention program","volume":"18","author":"Massad","year":"2004","journal-title":"AIDS"},{"key":"10.1157\/13123038_bb0185","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1468-1293.2005.00268.x","article-title":"Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection","volume":"6","author":"Torre","year":"2005","journal-title":"HIV Med"},{"key":"10.1157\/13123038_bb0190","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.ajog.2003.12.037","article-title":"Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus","volume":"190","author":"Massad","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1157\/13123038_bb0195","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(00)04578-5","article-title":"Effect of highly active antiretroviral therapy on frequency of oral warts","volume":"357","author":"Greenspan","year":"2001","journal-title":"Lancet"},{"key":"10.1157\/13123038_bb0200","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00002030-200301240-00028","article-title":"Lack of response of anal intra-epithelial neoplasia to highly active antiretroviral therapy","volume":"17","author":"Fox","year":"2003","journal-title":"AIDS"},{"key":"10.1157\/13123038_bb0205","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/338637","article-title":"Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection","volume":"34","author":"King","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13123038_bb0210","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.qai.0000159669.80207.12","article-title":"A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic","volume":"40","author":"Chiao","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1157\/13123038_bb0215","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.olq.0000162366.60245.02","article-title":"Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy","volume":"32","author":"Diamond","year":"2005","journal-title":"Sex Transm Dis"},{"key":"10.1157\/13123038_bb0220","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"key":"10.1157\/13123038_bb0225","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"key":"10.1157\/13123038_bb0230","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"A controlled trial of a human papillomavirus type 16 vaccine","volume":"347","author":"Koutsky","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1157\/13123038_bb0235","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised doubleblind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1157\/13123038_bb0240","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.AOG.0000192397.41191.fb","article-title":"Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial","volume":"107","author":"Mao","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1157\/13123038_bb0245","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1157\/13123038_bb0250","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/CVI.00478-06","article-title":"An evaluation of non-inferiority in antibody response to human papillomavirus (HPV) 16 in subjects vaccinated with monovalent (HPV 16) and quadrivalent (HPV 6, 11, 16, 18) L1 virus like particle vaccines","volume":"14","author":"Garland","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1157\/13123038_bb0255","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/rmv.498","article-title":"Human papillomavirus vaccines","volume":"16","author":"Stanley","year":"2006","journal-title":"Rev Med Virol"},{"key":"10.1157\/13123038_bb0260","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1258\/095646206778145550","article-title":"Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing","volume":"17","author":"Lehtinen","year":"2006","journal-title":"Int J STD AIDS"},{"key":"10.1157\/13123038_bb0265","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1258\/095646206776253453","article-title":"Population-based enrolment of adolescents in a long-term follow-up trial of human papillomavirus vaccine efficacy","volume":"17","author":"Lehtinen","year":"2006","journal-title":"Int J STD AIDS"},{"issue":"3 Suppl","key":"10.1157\/13123038_bb0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2223\/JPED.1492","article-title":"Vaccines against rotavirus and human papillomavirus (HPV)","volume":"82","author":"Linhares","year":"2006","journal-title":"J Pediatr (Rio J)"},{"issue":"Suppl 3","key":"10.1157\/13123038_bb0275","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.vaccine.2006.06.014","article-title":"Chapter 13: current findings from prophylactic HPV vaccine trials","volume":"24","author":"Koutsky","year":"2006","journal-title":"Vaccine"},{"key":"10.1157\/13123038_bb0280","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ygyno.2003.10.004","article-title":"Presence of multiple human papillomavirus types in cervical samples from HIV-infected women","volume":"92","author":"Levi","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1157\/13123038_bb0285","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jmv.20244","article-title":"Prevalence of human papillomavirus genotypes in women from three clinical settings","volume":"75","author":"Chaturvedi","year":"2005","journal-title":"J Med Virol"},{"issue":"Suppl 3","key":"10.1157\/13123038_bb0290","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.vaccine.2006.05.120","article-title":"Chapter 16: HPV vaccines in immunocompromised women and men","volume":"24","author":"Palefsky","year":"2006","journal-title":"Vaccine"},{"key":"10.1157\/13123038_bb0295","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1086\/346052","article-title":"Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women","volume":"187","author":"Viscidi","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1157\/13123038_bb0300","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/01.aids.0000253361.63578.14","article-title":"Human papillomavirus types among women infected with HIV: a meta-analysis","volume":"20","author":"Clifford","year":"2006","journal-title":"Aids"},{"key":"10.1157\/13123038_bb0305","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jac\/dkl073","article-title":"Human papillomavirus viral load: a possible marker for cervical disease in HIV-infected women","volume":"57","author":"Lillo","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1157\/13123038_bb0310","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1158\/0008-5472.CAN-04-1091","article-title":"Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection","volume":"64","author":"Kobayashi","year":"2004","journal-title":"Cancer Res"},{"key":"10.1157\/13123038_bb0315","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1086\/315815","article-title":"The impact of human immunodeficiency virus type 1 status on human papillomavirus (HPV) prevalence and HPV antibodies in serum and cervical secretions","volume":"182","author":"Marais","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1157\/13123038_bb0320","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jnci\/dji073","article-title":"Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women","volume":"97","author":"Strickler","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 10A","key":"10.1157\/13123038_bb0325","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.amjmed.2005.07.024","article-title":"Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus","volume":"118","author":"Laurence","year":"2005","journal-title":"Am J Med"},{"key":"10.1157\/13123038_bb0330","first-page":"5205","article-title":"Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia","volume":"9","author":"Baldwin","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1157\/13123038_bb0335","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1016\/j.vaccine.2004.01.049","article-title":"Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV 16\/18 E6E7)","volume":"22","author":"Davidson","year":"2004","journal-title":"Vaccine"},{"key":"10.1157\/13123038_bb0340","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri1260","article-title":"Prevention of cervical cancer through papillomavirus vaccination","volume":"4","author":"Frazer","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1157\/13123038_bb0345","doi-asserted-by":"crossref","first-page":"8386","DOI":"10.1128\/JVI.77.15.8386-8393.2003","article-title":"Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16","volume":"77","author":"Varsani","year":"2003","journal-title":"J Virol"},{"key":"10.1157\/13123038_bb0350","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.virol.2005.04.011","article-title":"Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2","volume":"337","author":"Pastrana","year":"2005","journal-title":"Virology"},{"key":"10.1157\/13123038_bb0355","first-page":"472","article-title":"Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects","volume":"62","author":"De Jong","year":"2002","journal-title":"Cancer Res"},{"key":"10.1157\/13123038_bb0360","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/10430340460745757","article-title":"Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus","volume":"15","author":"Corona Guti\u00e9rrez","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1157\/13123038_bb0365","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1016\/S0264-410X(02)00350-X","article-title":"Enhancement of human papillomavirus (HPV) type 16 E6 and E7-specific T-cell immunity in healthy volunteers through vaccination with TA-CIN, an HPV16 L2E7E6 fusion protein vaccine","volume":"20","author":"De Jong","year":"2002","journal-title":"Vaccine"},{"key":"10.1157\/13123038_bb0370","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0188-0128(99)00026-3","article-title":"Chimeric viruslike particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and therapeutic vaccine","volume":"30","author":"Jochmus","year":"1999","journal-title":"Arch Med Res"},{"key":"10.1157\/13123038_bb0375","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1016\/S0264-410X(03)00454-7","article-title":"Safety and immunogenicity of a peptide containing the cross-neutralization epitope of HPV16 L2 administered nasally in healthy volunteers","volume":"21","author":"Kawana","year":"2003","journal-title":"Vaccine"},{"key":"10.1157\/13123038_bb0380","doi-asserted-by":"crossref","first-page":"8702","DOI":"10.1128\/JVI.77.16.8702-8711.2003","article-title":"Oral immunogenicity of human papillomavirus-like particles expressed in potato","volume":"77","author":"Warzecha","year":"2003","journal-title":"J Virol"},{"key":"10.1157\/13123038_bb0385","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1016\/j.vaccine.2005.02.019","article-title":"Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine","volume":"23","author":"Nardelli-Haefliger","year":"2005","journal-title":"Vaccine"},{"key":"10.1157\/13123038_bb0390","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.virusres.2005.02.001","article-title":"A human papillomavirus type 16 vaccine by oral delivery of L1 protein","volume":"110","author":"Sasagawa","year":"2005","journal-title":"Virus Res"},{"key":"10.1157\/13123038_bb0395","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.vaccine.2003.11.064","article-title":"Pluronic F127-based systemic vaccine delivery systems","volume":"22","author":"Coeshott","year":"2004","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1157\/13123038_bb0400","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.vaccine.2006.05.123","article-title":"Chapter 17: second generation HPV vaccines to prevent cervical cancer","volume":"24","author":"Schiller","year":"2006","journal-title":"Vaccine"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775308715938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775308715938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T21:44:41Z","timestamp":1684532681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775308715938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0025775308715938"],"URL":"https:\/\/doi.org\/10.1157\/13123038","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}